Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
03/2000
03/30/2000WO2000017175A1 INHIBITORS OF p38
03/30/2000WO2000017163A1 Cyanophenyl derivatives
03/30/2000WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000WO2000016763A2 Antimalarial agents
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000CA2344913A1 Antimalarial agents
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/29/2000EP0989122A1 Process for the preparation of imidazolidine-2,4-diones
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988290A1 Carbonyldiimidazoles, their ester derivatives and method for their production
03/29/2000EP0988262A1 Bromination process
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/28/2000US6043377 Imidazole compounds
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043284 Anti-atherosclerotic diaryl compounds
03/28/2000US6043247 Modulators of molecules with phosphotyrosine recognition units
03/28/2000US6043218 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
03/28/2000CA2180978C Pyrrolidine-containing monomers and oligomers
03/28/2000CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
03/28/2000CA2056662C Naphthoic acid derivative
03/28/2000CA2001003C Olefinically unsaturated compounds, a process for the production of copolymers containing isocyanate groups, the copolymers thus obtained and coating compositions or sealing compounds containing the copolymers
03/23/2000WO2000015634A2 Hiv protease inhibitors
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000DE19940211A1 Single stage, high yield preparation of imidazolidine-2,4-diones useful as aminoacid intermediates, from aldehyde, (thio)urea compound and carbon monoxide over metal compound catalyst
03/23/2000CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0986551A1 Sulfonamide derivatives, their production and use
03/22/2000EP0986544A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
03/22/2000EP0986539A1 Dna-binding pyrrole and imidazole polyamide derivatives
03/22/2000EP0986534A2 Organic compounds
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000EP0986302A1 A method of treating cancer
03/22/2000CN1248247A Method of producing N, N'-diazole compounds
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/22/2000CA2282915A1 Process for the preparation of imidazolidine-2,4-diones
03/21/2000US6040457 Process for the preparation of formylimidazoles
03/21/2000US6040439 Method for chemical synthesis of oligonucleotides
03/21/2000US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability
03/21/2000US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040320 Antiinflammatory agent for treating diseases associated with overproduction of inflammatory cytokines, such as rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, and osteoarthritis
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound
03/16/2000WO2000014072A1 Method for producing carbonyldiimidazole
03/16/2000WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/15/2000EP0985668A1 Process for preparation of 1,3-dimethyl-imidazolium-4-carboxylate
03/15/2000EP0985659A1 Process for the preparation of 3-cyano-3,5,5-trimethylcyclohexanone
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984926A2 Building blocks derived from 1,2-aminoalcohols
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000CN1247539A Process for preparing eprosartan
03/15/2000CN1247538A Process for preparing eprosartan
03/15/2000CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1050353C Process for prepn. of alkylimidazolidone (meth)-acrylates
03/14/2000USRE36617 (Substituted aralkyl) heterocyclic compounds
03/14/2000US6037474 Process for the preparation of cyclic 4-oxoamidines
03/14/2000US6037469 Beta lactamase inhibitor and antibacterial; for treating bacterial infections in humans and animals
03/14/2000US6037367 Substituted-pent-4-ynoic acids
03/14/2000CA2125895C Heteroatom-bearing ligands and metal complexes thereof
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO1999062893A3 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0984007A1 Cationic orthophenylenediamines, their use for the oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods
03/08/2000EP0984006A1 Cationic compounds, their use for the oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods
03/08/2000EP0983420A1 Low toxicity corrosion inhibitor
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983264A1 Method of manufacturing sertindole
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983229A1 Metalloproteinase inhibitors
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0738711B1 Novel 1,3-dialkylurea derivative having hydroxyl group
03/08/2000CN1246847A Nitrogen containing heteroaromatics as factor Xa inhibitors
03/07/2000US6034275 Tertiary amines
03/07/2000US6034251 Phenyl-alkyl-imidazoles
03/07/2000US6034250 Nitrone compounds
03/07/2000US6034249 Photographic sensitizers
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034137 Cationic lipids for gene therapy
03/07/2000US6033825 Containing a hydrazine compound and a contrast-boosting amino compound and/or phosphonium compound, and the silver halide emulsion layer or in a layer in a reactive relationship therewith, contains a vinyllactam polymer
03/02/2000WO2000011125A1 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
03/02/2000WO2000011041A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent
03/02/2000WO2000010565A1 Growth hormone secretagogues
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341007A1 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 345